Threshold Concentration of Unbound Bilirubin to Induce Neurological Deficits in a Patient with Type I Crigler—Najjar Syndrome

Based on the clinical course of a 16-year-old boy with type I Crigler-Najjar syndrome, we estimated the threshold concentration of unbound bilirubin, as assayed by the horseradish peroxidase method, that apparently induces toxicity to the brain. Before the age of 15, the patient did not manifest any neurological or behavioural dysfunction despite increased bilirubin in serum. The binding affinity and the binding capacity of the patient's serum albumin for bilirubin determined when he was about 14 years old were 108(mol/L)−1 and 1·01 to 1·04 mol/L, respectively. These values were nearly the same as those of normal controls reported in the literature. The total bilirubin binding capacity was greater than the patient's total bilirubin concentration, showing that his serum albumin was not saturated with bilirubin. The reserve bilirubin binding capacity (RBBC) was estimated to be 158 μmol/L and the unbound bilirubin concentration to be 15·1 nmol/L. Concentration of unbound bilirubin peaked at 21·7 nmol/L at the age of 15 years and 11 months, i.e. 2 months before the onset of difficulties in walking and speaking. At this time, the RBBC was estimated as −64 μmol/L. A peak concentration of total bilirubin, 811 μmol/L, was observed during the period of rapid loss of the ability to walk or speak. At the age of 16 years and 1 month the RBBC decreased to −98 μmol/L and the unbound bilirubin concentration to 18·8 nmol/L. Following phototherapy, the patient's neurological state returned to normal; he could speak and walk normally. At the age of 16 years and 2 months the RBBC returned to 105 μmol/L and unbound bilirubin decreased to 16·6 nmol/L. These results suggest that maintaining the concentration of unbound bilirubin at < 20 nmol/L and the total bilirubin concentration at lower than the binding capacity of serum albumin is important for prevention of neurological deficits in Crigler-Najjar syndrome. The upper limit of unbound bilirubin in such an older patient was nearly the same as that reported for newborns.

[1]  P. Bosma,et al.  Jaundice and disorders of bilirubin metabolism , 1998 .

[2]  O. Koiwai,et al.  Three Japanese patients with Crigler-Najjar syndrome type I carry an identical nonsense mutation in the gene for UDP-glucuronosyltransferase , 1995, Japanese Journal of Human Genetics.

[3]  H. Ihara,et al.  Unexpected Presence of Delta Bilirubin in the Serum of a Patient with Type I Crigler-Najjar Syndrome Observed by a Kodak Ektachem 700N Analyzer , 1992 .

[4]  B. Gridelli,et al.  Orthotopic liver transplantation for type I Crigler‐Najjar syndrome , 1986, Hepatology.

[5]  R. Mccomb,et al.  Candidate reference method for determination of total bilirubin in serum: development and validation. , 1985, Clinical chemistry.

[6]  R. Mooney,et al.  Free bilirubin measurements in a patient with Crigler-Najjar syndrome after crush injury. , 1983, The Journal of pediatrics.

[7]  A. Robertson,et al.  Predicting the Need for Exchange Transfusion in Newborn Infants , 1983, Clinical pediatrics.

[8]  W. Oh,et al.  Unbound bilirubin and kernicterus in low-birth-weight infants. , 1982, Pediatrics.

[9]  D. Lightner,et al.  Blue light and bilirubin excretion. , 1980, Science.

[10]  W. Karp Biochemical alterations in neonatal hyperbilirubinemia and bilirubin encephalopathy: a review. , 1979, Pediatrics.

[11]  W. Oh,et al.  Serum Bilirubin Binding Capacity and Free Bilirubin Concentration: A Comparison between Sephadex G-25 Filtration and Peroxidase Oxidation Techniques , 1978, Pediatric Research.

[12]  N. Hajime,et al.  Microdetermination of unbound bilirubin in icteric newborn sera: An enzymatic method employing peroxidase and glucose oxidase , 1977 .

[13]  R. Brodersen PREVENTION OF KERNICTERUS, BASED ON RECENT PROGRESS IN BILIRUBIN CHEMISTRY , 1977, Acta paediatrica Scandinavica.

[14]  Y. Lee,et al.  Microdetermination of unbound bilirubin in icteric newborn sera: an enzymatic method employing peroxidase and glucose oxidase. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[15]  R. Wennberg,et al.  Determination of unbound bilirubin in the serum of newborns. , 1974, Clinical chemistry.

[16]  T. Blaschke,et al.  Crigler-Najjar Syndrome: An Unusual Course with Development of Neurologic Damage at Age Eighteen , 1974, Pediatric Research.

[17]  W. Watson,et al.  Albumin standards and the measurement of serum albumin with bromcresol green. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[18]  J. Jacobsen Binding of bilirubin to human serum albumin — determination of the dissociation constants , 1969, FEBS letters.

[19]  B. Childs,et al.  Familial nonhemolytic jaundice with late onset of neurological damage. , 1968, Pediatrics.

[20]  R. Schmid,et al.  Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system. , 1966, The Journal of clinical investigation.

[21]  L. Ernster,et al.  Experimental studies on the pathogenesis of kernicterus. , 1957, Pediatrics.

[22]  L. Bakay Studies on blood-brain barrier with radioactive phosphorus. III. Embryonic development of the barrier. , 1953, A.M.A. archives of neurology and psychiatry.

[23]  J. Crigler,et al.  Congenital familial nonhemolytic jaundice with kernicterus. , 1952, Pediatrics.